Biosimilars
Biotech
Fresenius Kabi’s Idacio (adalimumab, biosimilar) Receives EU’s Marketing Approval in
Shots: The approval is based on its non-inferiority data consisting of its PK, efficacy, safety, immunogenicity data with the reference product in analytical, preclinical and clinical data trials Fresenius Kabi […]readmore